APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical & Biotechnology Environmental Monitoring

Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug products. While requirements for the control of both viable (living microorganisms) and non-viable particles (e.g. dust, hair, etc.) and other contaminants (i.e. trace metals, volatiles, etc.) for aseptic manufacturing operations are more extensive than those for non-sterile processes, the quantity of samples that must be analyzed and the amount of data generated can be daunting regardless of the final drug form, particularly for global companies with multiple production facilities.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug products. While requirements for the control of both viable (living microorganisms) and non-viable particles (e.g. dust, hair, etc.) and other contaminants (i.e. trace metals, volatiles, etc.) for aseptic manufacturing operations are more extensive than those for non-sterile processes, the quantity of samples that must be analyzed and the amount of data generated can be daunting regardless of the final drug form, particularly for global companies with multiple production facilities.

This report studies the Pharmaceutical & Biotechnology Environmental Monitoring market. It covered Monitoring Equipment, Media, Reagents & Kits, Microbiology Services, Environmental Monitoring and Software used in Pharmaceutical & Biotechnology Environmental Monitoring.

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical & Biotechnology Environmental Monitoring Market Outlook and Growth Opportunities 2026

25 December 2025194 pages

Choose your research edition.

Industry ResearchPharmaceutical & Biotechnology Environmental Monitoring Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical & Biotechnology Environmental Monitoring Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pharmaceutical & Biotechnology Environmental Monitoring Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical & Biotechnology Environmental Monitoring Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical & Biotechnology Environmental Monitoring Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug products. While requirements for the control of both viable (living microorganisms) and non-viable particles (e.g. dust, hair, etc.) and other contaminants (i.e. trace metals, volatiles, etc.) for aseptic manufacturing operations are more extensive than those for non-sterile processes, the quantity of samples that must be analyzed and the amount of data generated can be daunting regardless of the final drug form, particularly for global companies with multiple production facilities.

This report studies the Pharmaceutical & Biotechnology Environmental Monitoring market. It covered Monitoring Equipment, Media, Reagents & Kits, Microbiology Services, Environmental Monitoring and Software used in Pharmaceutical & Biotechnology Environmental Monitoring.

Danaher Corporation, Thermo Fisher Scientific, Merck KGAA, Eurofins Sinensis and Lonza are the leading productors of Pharmaceutical & Biotechnology Environmental Monitoring. The top three accounted for about 20% of the total market.

Read the full market overview

North America is the largest market, accounting for about 40%. Europe is next with about 25%.

This report provides an overview of the global Pharmaceutical & Biotechnology Environmental Monitoring market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical & Biotechnology Environmental Monitoring and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical & Biotechnology Environmental Monitoring revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical & Biotechnology Environmental Monitoring market.

Pharmaceutical & Biotechnology Environmental Monitoring Segment by Company

Danaher Corporation

Thermo Fisher Scientific

Merck KGaA

Eurofins Sinensis

Lonza

Biomerieux

VAI

Cosasco

RMONI

Amphenol Advanced Sensors

Vaisala

Pharmaceutical & Biotechnology Environmental Monitoring Segment by Type

Monitoring Equipment

Media

Software

Microbiology Services

Pharmaceutical & Biotechnology Environmental Monitoring Segment by Application

Pharmaceutical Industry

Biotechnology Industry

Academic & Research Institutes

Pharmaceutical & Biotechnology Environmental Monitoring Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical & Biotechnology Environmental Monitoring status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical & Biotechnology Environmental Monitoring key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical & Biotechnology Environmental Monitoring breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical & Biotechnology Environmental Monitoring market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical & Biotechnology Environmental Monitoring significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical & Biotechnology Environmental Monitoring competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical & Biotechnology Environmental Monitoring market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical & Biotechnology Environmental Monitoring and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical & Biotechnology Environmental Monitoring.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical & Biotechnology Environmental Monitoring industry.

Chapter 3: Detailed analysis of Pharmaceutical & Biotechnology Environmental Monitoring company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical & Biotechnology Environmental Monitoring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical & Biotechnology Environmental Monitoring in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical & Biotechnology Environmental Monitoring Industry Trends Table 2. Pharmaceutical & Biotechnology Environmental Monitoring Industry Drivers Table 3. Pharmaceutical & Biotechnology Environmental Monitoring Industry Opportunities and Challenges Table 4. Pharmaceutical & Biotechnology Environmental Monitoring Industry Restraints Table 5. Global Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical & Biotechnology Environmental Monitoring Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical & Biotechnology Environmental Monitoring Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical & Biotechnology Environmental Monitoring Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical & Biotechnology Environmental Monitoring Company, Product Type & Application Table 10. Global Pharmaceutical & Biotechnology Environmental Monitoring Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical & Biotechnology Environmental Monitoring by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Monitoring Equipment Table 15. Significant Companies of Media Table 16. Significant Companies of Software Table 17. Significant Companies of Microbiology Services Table 18. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type (2021-2026) Table 22. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Industry Table 24. Significant Companies of Biotechnology Industry Table 25. Significant Companies of Academic & Research Institutes Table 26. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application (2021-2026) Table 30. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application (2027-2032) Table 31. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Region (2021-2026) Table 34. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Region (2027-2032) Table 36. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Market Share by Country (2021-2026) Table 39. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Market Share by Country (2027-2032) Table 41. Danaher Corporation Company Information Table 42. Danaher Corporation Business Overview Table 43. Danaher Corporation Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Danaher Corporation Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio Table 45. Danaher Corporation Recent Development Table 46. Thermo Fisher Scientific Company Information Table 47. Thermo Fisher Scientific Business Overview Table 48. Thermo Fisher Scientific Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Thermo Fisher Scientific Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio Table 50. Thermo Fisher Scientific Recent Development Table 51. Merck KGaA Company Information Table 52. Merck KGaA Business Overview Table 53. Merck KGaA Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Merck KGaA Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio Table 55. Merck KGaA Recent Development Table 56. Eurofins Sinensis Company Information Table 57. Eurofins Sinensis Business Overview Table 58. Eurofins Sinensis Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Eurofins Sinensis Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio Table 60. Eurofins Sinensis Recent Development Table 61. Lonza Company Information Table 62. Lonza Business Overview Table 63. Lonza Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Lonza Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio Table 65. Lonza Recent Development Table 66. Biomerieux Company Information Table 67. Biomerieux Business Overview Table 68. Biomerieux Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Biomerieux Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio Table 70. Biomerieux Recent Development Table 71. VAI Company Information Table 72. VAI Business Overview Table 73. VAI Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. VAI Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio Table 75. VAI Recent Development Table 76. Cosasco Company Information Table 77. Cosasco Business Overview Table 78. Cosasco Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Cosasco Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio Table 80. Cosasco Recent Development Table 81. RMONI Company Information Table 82. RMONI Business Overview Table 83. RMONI Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. RMONI Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio Table 85. RMONI Recent Development Table 86. Amphenol Advanced Sensors Company Information Table 87. Amphenol Advanced Sensors Business Overview Table 88. Amphenol Advanced Sensors Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Amphenol Advanced Sensors Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio Table 90. Amphenol Advanced Sensors Recent Development Table 91. Vaisala Company Information Table 92. Vaisala Business Overview Table 93. Vaisala Pharmaceutical & Biotechnology Environmental Monitoring Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Vaisala Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio Table 95. Vaisala Recent Development Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Pharmaceutical & Biotechnology Environmental Monitoring Product Image Figure 2. Global Pharmaceutical & Biotechnology Environmental Monitoring Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical & Biotechnology Environmental Monitoring Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical & Biotechnology Environmental Monitoring Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Monitoring Equipment Image Figure 8. Media Image Figure 9. Software Image Figure 10. Microbiology Services Image Figure 11. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Industry Image Figure 15. Biotechnology Industry Image Figure 16. Academic & Research Institutes Image Figure 17. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application (2021-2032) Figure 20. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (2021-2032) & (US$ Million) Figure 23. North America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (2021-2032) & (US$ Million) Figure 29. South America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Monitoring Equipment
  • Media
  • Software
  • Microbiology Services
Applications
  • Pharmaceutical Industry
  • Biotechnology Industry
  • Academic & Research Institutes
Companies covered
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Merck KGaA
  • Eurofins Sinensis
  • Lonza
  • Biomerieux
  • VAI
  • Cosasco
  • RMONI
  • Amphenol Advanced Sensors
  • Vaisala

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical & Biotechnology Environmental Monitoring Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical & Biotechnology Environmental Monitoring Market Dynamics
  1. 2.1 Pharmaceutical & Biotechnology Environmental Monitoring Industry Trends
  2. 2.2 Pharmaceutical & Biotechnology Environmental Monitoring Industry Drivers
  3. 2.3 Pharmaceutical & Biotechnology Environmental Monitoring Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical & Biotechnology Environmental Monitoring Industry Restraints
3 Pharmaceutical & Biotechnology Environmental Monitoring Market by Company
  1. 3.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical & Biotechnology Environmental Monitoring Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical & Biotechnology Environmental Monitoring Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical & Biotechnology Environmental Monitoring Company Product Type and Application
  6. 3.6 Global Pharmaceutical & Biotechnology Environmental Monitoring Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical & Biotechnology Environmental Monitoring Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical & Biotechnology Environmental Monitoring Market by Type
  1. 4.1 Pharmaceutical & Biotechnology Environmental Monitoring Type Introduction
  2. 4.1.1 Monitoring Equipment
  3. 4.1.2 Media
  4. 4.1.3 Software
  5. 4.1.4 Microbiology Services
  6. 4.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type
  7. 4.2.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type (2021-2032)
5 Pharmaceutical & Biotechnology Environmental Monitoring Market by Application
  1. 5.1 Pharmaceutical & Biotechnology Environmental Monitoring Application Introduction
  2. 5.1.1 Pharmaceutical Industry
  3. 5.1.2 Biotechnology Industry
  4. 5.1.3 Academic & Research Institutes
  5. 5.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application
  6. 5.2.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application (2021-2032)
6 Pharmaceutical & Biotechnology Environmental Monitoring Regional Value Analysis
  1. 6.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical & Biotechnology Environmental Monitoring Country-level Value Analysis
  1. 7.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Danaher Corporation
  2. 8.1.1 Danaher Corporation Company Information
  3. 8.1.2 Danaher Corporation Business Overview
  4. 8.1.3 Danaher Corporation Pharmaceutical & Biotechnology Environmental Monitoring Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Danaher Corporation Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
  6. 8.1.5 Danaher Corporation Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Pharmaceutical & Biotechnology Environmental Monitoring Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Merck KGaA
  14. 8.3.1 Merck KGaA Company Information
  15. 8.3.2 Merck KGaA Business Overview
  16. 8.3.3 Merck KGaA Pharmaceutical & Biotechnology Environmental Monitoring Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck KGaA Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
  18. 8.3.5 Merck KGaA Recent Developments
  19. 8.4 Eurofins Sinensis
  20. 8.4.1 Eurofins Sinensis Company Information
  21. 8.4.2 Eurofins Sinensis Business Overview
  22. 8.4.3 Eurofins Sinensis Pharmaceutical & Biotechnology Environmental Monitoring Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eurofins Sinensis Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
  24. 8.4.5 Eurofins Sinensis Recent Developments
  25. 8.5 Lonza
  26. 8.5.1 Lonza Company Information
  27. 8.5.2 Lonza Business Overview
  28. 8.5.3 Lonza Pharmaceutical & Biotechnology Environmental Monitoring Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lonza Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
  30. 8.5.5 Lonza Recent Developments
  31. 8.6 Biomerieux
  32. 8.6.1 Biomerieux Company Information
  33. 8.6.2 Biomerieux Business Overview
  34. 8.6.3 Biomerieux Pharmaceutical & Biotechnology Environmental Monitoring Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Biomerieux Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
  36. 8.6.5 Biomerieux Recent Developments
  37. 8.7 VAI
  38. 8.7.1 VAI Company Information
  39. 8.7.2 VAI Business Overview
  40. 8.7.3 VAI Pharmaceutical & Biotechnology Environmental Monitoring Revenue and Gross Margin (2021-2026)
  41. 8.7.4 VAI Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
  42. 8.7.5 VAI Recent Developments
  43. 8.8 Cosasco
  44. 8.8.1 Cosasco Company Information
  45. 8.8.2 Cosasco Business Overview
  46. 8.8.3 Cosasco Pharmaceutical & Biotechnology Environmental Monitoring Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cosasco Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
  48. 8.8.5 Cosasco Recent Developments
  49. 8.9 RMONI
  50. 8.9.1 RMONI Company Information
  51. 8.9.2 RMONI Business Overview
  52. 8.9.3 RMONI Pharmaceutical & Biotechnology Environmental Monitoring Revenue and Gross Margin (2021-2026)
  53. 8.9.4 RMONI Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
  54. 8.9.5 RMONI Recent Developments
  55. 8.10 Amphenol Advanced Sensors
  56. 8.10.1 Amphenol Advanced Sensors Company Information
  57. 8.10.2 Amphenol Advanced Sensors Business Overview
  58. 8.10.3 Amphenol Advanced Sensors Pharmaceutical & Biotechnology Environmental Monitoring Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Amphenol Advanced Sensors Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
  60. 8.10.5 Amphenol Advanced Sensors Recent Developments
  61. 8.11 Vaisala
  62. 8.11.1 Vaisala Company Information
  63. 8.11.2 Vaisala Business Overview
  64. 8.11.3 Vaisala Pharmaceutical & Biotechnology Environmental Monitoring Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Vaisala Pharmaceutical & Biotechnology Environmental Monitoring Product Portfolio
  66. 8.11.5 Vaisala Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst